Navigation Links
AADR testifies to the FDA advisory panel on dental amalgam
Date:12/22/2010

Gaithersburg, MD On December 14-15, 2010, the U.S. Food and Drug Administration (FDA) convened an Advisory Panel to discuss several scientific issues that may affect the regulation of dental amalgam. At the conclusion of the hearing, the Panel voted to recommend that the FDA conduct further review of the material's safety.

The meeting comes on the heels of a July 2009 Final Rule (http://bit.ly/FDA2009FinalRule) from the FDA that reclassified dental mercury from a class I device to a class II device and designated special controls for dental amalgam, mercury and amalgam alloy. The 2009 ruling was the culmination of seven years of deliberation by the FDA and confirmed the safety of dental amalgam for use in all populations.

The Final Rule noted that "scientific studies using the most reliable methods have shown that dental amalgam exposes adults to amounts of elemental mercury vapor below or approximately equivalent to the protective levels of exposure identified by Agency for Toxic Substances and Disease Registry (ATSDR) and Environmental Protection Agency (EPA)."

On December 14, Dr. Mary Tavares, DMD, MPH, testified (http://bit.ly/FDA_Testimony) on behalf of the American Association for Dental Research (AADR) during the first day of the Advisory Panel meeting. Dr. Tavares, a Senior Investigator at the Forsyth Institute and a co-Principle Investigator on the New England Children's Dental Amalgam Trial (Bellinger DC et al), stated that "no statistically significant differences in adverse neuropsychological or renal effects were observed in children whose teeth were restored with dental amalgam compared to composite resin." The five year clinical trial, which ended in 2006, was reported in the Journal of the American Medical Association and funded by the National Institute of Dental and Craniofacial Research (NIDCR).

AADR continues to support the findings from the FDA 2009 Final Rule and the Association also supports the continual review of new scientific information regarding the safety of all dental products and materials, as it becomes available.


'/>"/>

Contact: Ingrid L. Thomas
ithomas@aadronline.org
703-299-8084
International & American Association for Dental Research
Source:Eurekalert

Related medicine news :

1. Meharry Medical College President Testifies Before the U.S. House of Representatives
2. Dr. Corey Hebert Testifies Before Congress on Safety of FEMA Trailers
3. Society of Corporate Compliance and Ethics Testifies at U.S. Sentencing Commission March 17, 2010 Hearing on Proposed Amendments
4. American Dental Association President Testifies Before IOM Committee on Access to Oral Health Care
5. openQ Announces the Formation of a Compliance Advisory Board
6. 'Dr. Richard W. Droste Joins the Novus Life Nutrition Medical Advisory Board'
7. Health Justice CT Forms Advisory Board to Raise Awareness About Health Care Quality
8. The Walden Group, a Specialized Strategic Healthcare Investment Banking Firm, Adds Key Advisory Services
9. MEDIA ADVISORY: Let's Move L.A. Inaugural Event and Launch Party. April 28th, 2010. 11am - 2pm.
10. Media Advisory: Wisconsin Governor, Legislators to be Honored for Seat Belt law
11. GOOD Adds Depth to Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... Student-doctors from Western ... (AOA) Match Program Tuesday, February 9, taking one of the final steps in ... medical education positions across the country. Of the 103 student-doctors who comprise the ...
(Date:2/11/2016)... ... 12, 2016 , ... The Journal of Pain Research has seen ... SJR uses data taken from the Scopus database (Elsevier B.V.) and is a measure ... by the journal over a three year period and also the importance of the ...
(Date:2/11/2016)... ... ... Hall Integrative Health and Chiropractic, PC which focuses on ... in March. All seven practices are set to start accepting patients in March ... According to this 2011 CNN article it is possible: http://www.cnn.com/2011/HEALTH/01/28/reverse.diabetes/ . Current ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... upcoming Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for Plans ... Catholic health care system that’s partnering with Intel on value-based health benefits program ...
(Date:2/11/2016)... ... , ... PharmMD CEO Robert Yeager announced today ... contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include healthcare ... breaches for the Part D Star Rating improvement and Medication Therapy Management firm. ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... , Feb. 11, 2016 Brain Cancer ... treatment method at West Cancer Center . ... fields to inhibit cancer cell replication causing death of ... than a decade to show a significant extension in ... (GBM) patients. Currently, West Cancer Center is the only ...
(Date:2/11/2016)... , Feb. 11, 2016  AbbVie, a ... AbbVie Rheumatology Scholarship, designed to provide financial support ... as they pursue higher education goals. Fifteen scholars ... the 2016-2017 school year. The AbbVie Rheumatology Scholarship ... Haas , vice president, corporate social responsibility, brand ...
(Date:2/11/2016)... 11, 2016 PLAD, Inc. (OTC Pink: PLAD) is ... sales exceeding company targets, are adding key personnel to ... from the United States Patent and Trademark Office for ... Executive Officer of PLAD, Inc.  In January, PLAD established ... with two new customers, Cumberland Goodwill EMS ...
Breaking Medicine Technology: